Pulling Out All the Stops to Sell More COVID Shots
This year, Pfizer, Inc. and Moderna, Inc. have experienced sharply declining sales of their messenger RNA (mRNA) COVID-19 shots, Comirnaty and Spikevax. Pfizer reported first-quarter (ending Mar. 31, 2023) sales of $3 billion for Comirnaty—down 75 percent from the same period in 2022. It posted second-quarter (ending June 30) sales of $1.49 billion—down 83 percent […]